A sample of the silver-containing sodium carboxymethyl cellulose wound dressing was aseptically transferred to a simulated wound fluid containing A. baumannii, C. difficile, community-associated MRSA or ESBL-producing bacteria. Following incubation, total viable counts were performed on each test model at four, 24, 48, 72, and 96 hours and at seven days. All models were re-inoculated with a fresh challenge of the same bacteria at 72 hours.
The dressing killed ESBL-producing bacteria and A. baumannii quickly and consistently, with an approximate 100,000-fold reduction of all pathogens within 24 hours. The rate of kill for C. difficile was rapid, with an approximate 100,000-fold reduction of all bacteria after four hours. The wound dressing also was effective against CA-MRSA, with a 100-fold reduction in bacterial population within 48 hours and no bacteria detected by day seven.
Read the news release about ionic silver wound dressing.
Read other coverage about infection control:
– Influenza, Hep B Vaccination Among Healthcare Personnel Remains Low
– Honey May Help in Fight Against Antibiotic-Resistant Bacteria
– ASHE, APIC Release Joint Statement Following Recent Johns Hopkins Faucet Study
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
